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Abstract
Objective:  To  determine  eight  parameters  of  oxidative  stress  markers  in  erythrocytes  from
children with  sickle  cell  disease  and  compare  with  the  same  parameters  in  erythrocytes  from
healthy children,  since  oxidative  stress  plays  an  important  role  in  the  pathophysiology  of  sickle
cell disease  and  because  this  disease  is  a  serious  public  health  problem  in  many  countries.
Methods: Blood  samples  were  obtained  from  45  children  with  sickle  cell  disease  (21  males
and 24  females  with  a  mean  age  of  9  years;  range:  3--13  years)  and  280  blood  samples  were
obtained  from  children  without  hemoglobinopathies  (137  males  and  143  females  with  a  mean
age of  10  years;  range:  8--11  years),  as  a  control  group.  All  blood  samples  were  analyzed  for
methemoglobin,  reduced  glutathione,  thiobarbituric  acid  reactive  substances,  percentage  of
hemolysis,  reactive  oxygen  species,  and  activity  of  the  enzymes  glucose  6-phosphate  dehydro-
genase, superoxide  dismutase,  and  catalase.  Data  were  analyzed  using  Student’s  t-test  and  were
expressed as  the  mean  ±  standard  deviation.  A  p-value  of  <0.05  was  considered  signiﬁcant.
Results:  Signiﬁcant  differences  were  observed  between  children  with  sickle  cell  disease  and
the control  group  for  the  parameters  methemoglobin,  thiobarbituric  acid  reactive  substances,
hemolysis,  glucose  6-phosphate  dehydrogenase  activity,  and  reactive  oxygen  species,  with
higher levels  in  the  patients  than  in  the  controls.
 Please cite this article as: Hermann PB, Pianovski MA, Henneberg R, Nascimento AJ, Leonart MS. Erythrocyte oxidative stress markers in
hildren with sickle cell disease. J Pediatr (Rio J). 2016;92:394--9.
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Conclusions:  Oxidative  stress  parameters  in  children’s  erythrocytes  were  determined  using  sim-
ple laboratory  methods  with  small  volumes  of  blood;  these  biomarkers  can  be  useful  to  evaluate
disease progression  and  outcomes  in  patients.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
PALAVRAS-CHAVE
Estresse  oxidativo;
Doenc¸a  falciforme;
Crianc¸as
Marcadores  de  estresse  oxidativo  em  eritrócitos  de  crianc¸as com  doenc¸a falciforme
Resumo
Objetivo:  Determinar  parâmetros  de  estresse  oxidativo  em  eritrócitos  de  crianc¸as  com  doenc¸a
falciforme e  compará-los  com  os  mesmos  parâmetros  em  eritrócitos  de  crianc¸as  saudáveis,  pois
o estresse  oxidativo  desempenha  um  importante  papel  na  ﬁsiopatologia  da  doenc¸a  falciforme,
considerada  um  sério  problema  de  saúde  pública  em  muitos  países.
Métodos:  Foram  obtidas  amostras  de  sangue  de  45  crianc¸as  com  doenc¸a  falciforme  (21  meninos
e 24  meninas  com  média  de  9  anos,  variac¸ão  de  3  a  13  anos)  e  280  amostras  de  sangue  de  crianc¸as
sem hemoglobinopatias  (137  meninos  e  143  meninas  com  média  de  10  anos,  variac¸ão  de  8  a
11 anos),  como  grupo  controle.  Em  todas  as  amostras  foram  determinados  meta-hemoglobina,
glutationa  reduzida,  substâncias  reativas  ao  ácido  tiobarbitúrico,  porcentagem  de  hemólise,
espécies  reativas  de  oxigênio  e  atividade  das  enzimas  glucose6-fosfato  desidrogenase,  superóx-
ido dismutase  e  catalase.  Os  dados  foram  analisados  com  o  teste  t  de  Student  e  foram  expressos
como média  ±  desvio  padrão.  Um  valor  de  p  <  0,05  foi  considerado  signiﬁcativo.
Resultados:  Foram  observadas  diferenc¸as  signiﬁcativas  entre  as  crianc¸as  com  doenc¸a  falciforme
e o  grupo  controle  para  os  parâmetros  meta-hemoglobina,  substâncias  reativas  ao  ácido  tio-
barbitúrico,  porcentagem  de  hemólise,  espécies  reativas  de  oxigênio  e  atividade  da  enzima
glucose6-fosfato  desidrogenase,  com  níveis  aumentados  nos  pacientes.
Conclusões:  Foi  possível  determinar  parâmetros  de  estresse  oxidativo  em  eritrócitos  de
crianc¸as, com  técnicas  laboratoriais  simples  e  pequenos  volumes  de  sangue.  Esses  biomar-
cadores podem  ser  úteis  na  avaliac¸ão  da  progressão  e  dos  resultados  de  tratamentos  da  doenc¸a.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
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Introduction
Sickle  cell  disease  is  one  of  the  most  common  hemato-
logic  disorders  in  the  world  and  is  a  serious  public  health
problem  in  many  countries,  including  Brazil.1 There  are
over  2  million  Brazilian  carriers  of  the  sickle  gene,  and
this  disease  is  estimated  to  have  an  incidence  of  one  in
every  1000  live  births.  In  2001,  a  decree  of  the  Ministry
of  Health  included  screening  for  hemoglobinopathies  in  the
pre-existing  screening  programs.2
Sickle  cell  disease  has  been  characterized  as  a  multi-
system  disease,  associated  with  episodes  of  acute  illness
and  progressive  organ  damage,  which  begins  in  infancy  and
is  primarily  responsible  for  a  shortened  life  expectancy  in
affected  patients.3 Rates  of  morbidity  and  mortality  are  still
high  for  patients  with  sickle  cell  disease.  In  Brazil,  up  to  25%
of  the  children  affected  died  during  their  ﬁrst  5  years  of  life,
but  early  diagnosis  and  treatment  might  reduce  these  rates
and  improve  their  quality  of  life.4
Sickle  hemoglobin  results  from  a  substitution  of  glu-
tamic  acid  to  valine  at  the  sixth  amino  acid  position  of
the  -globin  chain.5 This  ostensibly  minor  change  is  the
origin  of  hemoglobin  S,  and  is  responsible  for  signiﬁcant
changes  in  the  stability  and  solubility  of  the  molecule.6
The  tendency  of  deoxygenated  hemoglobin  S  to  undergo
polymerization  underlies  the  innumerable  expressions  of
the  sickling  syndromes  with  intravascular  hemolysis.7 Free
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lasma  hemoglobin  is  able  to  initiate  lipid  peroxidation,  and
he  heme,  which  readily  dissociates  from  methemoglobin,
ay  contribute  signiﬁcantly  to  oxidative  stress,8 which
ight  play  a  signiﬁcant  role  in  the  pathophysiology  of
ickle  cell  disease-related  microvascular  dysfunction,  vaso-
cclusion,  and  development  of  organ  damage.9 Biomarkers
f  oxidative  stress  can  therefore  be  potentially  useful,  both
o  identify  patients  who  are  at  high  risk  of  oxidative  damage
nd  to  evaluate  the  effects  of  anti-oxidative  therapies.10
The  purpose  of  this  work  was  to  evaluate  the  parameters
f  oxidative  stress  in  erythrocytes  from  children  with  sickle
ell  disease,  including  percentages  of  hemolysis,  methe-
oglobin,  reduced  glutathione,  thiobarbituric  acid-reactive
ubstances,  glucose  6-phosphate  dehydrogenase  activity,
eactive  oxygen  species,  and  the  anti-oxidant  enzymes  cata-
ase  and  superoxide  dismutase.
ethods
hemicals
eta-phosphoric  acid,  2-mercaptoethanol,  pyrogallol,  2,2-
zobis(2-amidinopropane)hydrochloride  (AAPH),  ethylene-
iaminetetraacetic  acid  (EDTA),  and  5,5-dithiobis-2-
itrobenzoic  acid  (DTNB)  were  obtained  from  Sigma--Aldrich
St.  Louis,  MO,  USA).  Sodium  and  potassium  phosphates,
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196  
aponin,  trichloroacetic  acid,  and  thiobarbituric  acid
ere  supplied  by  Vetec  Ltda  (Rio  de  Janeiro,  RJ,  Brazil).
odium  citrate,  tris(hydroxymethyl)aminomethane,  and
ethanol  were  obtained  from  Merck  (Darmstadt,  Ger-
any).  G6-PD  activity  was  determined  using  a  PD410  kit
y  Randox  Laboratories  (Antrim,  United  Kingdom).  All
rganic  solvents  were  of  high  quality  and  were  double-
istilled,  and  all  the  other  chemicals  were  of  analytical
rade.
lood  samples
lood  samples  were  obtained  from  45  children  diagnosed
ith  sickle  cell  disease  (21  males  and  24  females  with
 mean  age  of  9  years;  range:  3--13)  at  the  hematope-
iatric  department  of  Hospital  de  Clínicas,  Universidade
ederal  do  Paraná  (UFPR).  A  control  group  consisted  of  280
hildren  without  hemoglobinopathies  (137  males  and  143
emales  with  a  mean  age  of  10  years  old;  range:  8--11  years)
ho  were  participants  of  the  university  extension  project
ntitled  ‘‘Incidence  of  anemia  and  parasitic  infections  in
chool-aged  children  in  municipal  schools  of  metropolitan
egion  of  Curitiba-Parana  --  Brazil,’’  from  UFPR.  The  use
f  human  subjects  was  approved  by  the  Ethical  Committee
or  Research  Involving  Humans,  Hospital  de  Clínicas,  UFPR.
nformed  consent  was  obtained  from  the  guardians  for  all  the
hildren.  Children  with  any  hematological  alteration  were
xcluded  from  the  study.
A  venous  blood  sample  of  5  mL  was  collected  from  each
atient  in  K3-EDTA  coated  tubes.  Aliquots  (200  L)  of  whole
lood  were  separated  for  determination  of  G6-PD  activity.
hen,  samples  were  centrifuged  at  3000  ×  g  for  10  min.  The
lasma  and  the  buffy  coat  were  removed  by  aspiration,
nd  the  erythrocytes  were  washed  with  phosphate  buffered
aline  (PBS)  (NaCl,  150  mmol/L;  NaH2PO4,  1.9  mmol/L;  and
a2HPO4,  8.1  mmol/L)  three  times.  Finally,  red  blood  cells
ere  suspended  in  PBS  solution  and  water  to  obtain  suspen-
ions  with  hematocrits  of  approximately  10%  and  40%  for
BS  solution  and  of  approximately  40%  for  water  solution.
emoglobin  concentration  was  measured  in  all  suspensions.
ot  all  analyses  were  performed  in  each  specimen  due  to
he  limited  volumes  available.
ematologic  parameters
he  complete  blood  count  was  determined  using  the  Pentra
0  electronic  cell  counter  (Horiba  Medical,  Japan).
ethemoglobin  concentration
ethemoglobin  concentration  was  determined  according  to
 method  based  on  Naoum  et  al.11 adapted  to  small  vol-
mes.  Aliquots  (100  L)  of  10%  erythrocyte  suspensions  were
emolyzed  with  100  L  of  1%  saponin  and  were  stabilized
n  1000  L  of  60  mmol/L  phosphate  buffer;  the  absorbance
as  then  determined  at  630  nm  (for  methemoglobin)  and  at
40  nm  (for  oxyhemoglobin).  Methemoglobin  concentration
as  expressed  as  a  percentage  in  relation  to  hemoglobin
oncentration.
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educed  glutathione  determination
educed  glutathione  (GSH)  concentration  was  determined
y  a  method  previously  described  by  Beutler,12 by  evaluating
he  reduction  of  5,5′-dithiobis(2-nitrobenzoic  acid)  (DTNB)
y  sulfhydryl  compounds  from  the  formation  of  a  yellow  col-
red  anionic  product  whose  absorbance  was  measured  at
12  nm.  Aliquots  of  50  L  of  40%  suspension  of  red  blood  cell
n  PBS  were  used.  The  GSH  concentration  was  expressed  in
mol/gHb.
ipid  peroxidation
ipid  peroxidation  of  red  blood  cell  membranes  was  assessed
ased  on  Cesquini  et  al.13 Aliquots  (600  L)  of  a  10%  sus-
ension  of  red  blood  cell  were  added  to  250  L  of  25%
richloroacetic  acid  and  600  L  of  1%  thiobarbituric  acid,
oiled  for  15  min  at  100 ◦C,  and  cooled  for  5  min  at  0 ◦C.
he  absorbance  of  the  thiobarbituric  acid  reactive  sub-
tances  (TBARS)  formed  was  then  read  at  532  nm  using
 =  156/(mmole  cm)  and  the  concentrations  are  expressed  in
mol/gHb.
easurement  of  hemolysis
emolysis  of  red  blood  cell  was  carried  out  as  described
y  Banerjee  et  al.,14 adapted  to  microplates  by  mixing  10%
uspension  of  red  blood  cell  in  PBS  with  varying  amounts  of
APH  solution  (providing  ﬁnal  concentrations  of  50,  100,  and
50  mmol/L).  This  reaction  mixture  was  incubated  for  3  h  at
7 ◦C  with  shaking.  The  extent  of  hemolysis  was  determined
pectrophotometrically  by  measuring  the  absorbance  of  the
emolysate  at  540  nm  in  a  microplate  reader  (Thermo  Sci-
ntiﬁc,  Thermo  Plate,  USA).  Red  blood  cells  in  a  solution
f  200  mmol/L  of  AAPH  were  used  as  the  100%  hemolysis
ontrol.
ctivity  of  glucose6-phosphate  dehydrogenase
G6-PD)
liquots  (200  L)  of  whole  blood  before  erythrocyte  isola-
ion  were  washed  with  2  mL  PBS  three  times.  G6-PD  activity
as  determined  using  the  Cobas  Mira  automated  analyzer
Roche,  Mannheim,  Germany)  with  the  PD410  commercial
it  (Randox,  Antrim,  United  Kingdom)  as  described  in  the
anufacturer’s  manual.
uperoxide  dismutase  activity
he  enzyme  activity  was  based  on  a  method  adapted  from
eutler12 of  the  auto-oxidation  of  pyrogallol.  Aliquots  of
00  L  of  packed  red  blood  cell  were  hemolyzed  with  300  L
f  cold  deionized  water,  and  a  chloroform-ethanol  extract
as  prepared.  The  mixture  was  centrifuged  at  2300  ×  g  for
0  min.  Varying  amounts  of  the  clear  supernatant  extract  (0,
0,  40,  60,  80,  100  and  300  L)  were  added  to  a  solution  of
ris--HCl  and  water.  After  10  min,  20  L  of  a  1  mmol/L  pyro-
allol  solution  was  added  to  each  tube  and  the  absorbance
as  measured  at  412  nm  in  a  microplate.  The  amount  of
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Table  1  Hematological  values  in  healthy  children  (control  group)  and  patients  with  sickle  cell  disease.
Control  group  CV  Patients  CV  p
n =  280 n  =  45
RBC  (106/mm3)a 4.8  ±  0.3  7.0  3.2  ±  0.9  29.2  <0.001
Hemoglobin  (g/dl)a 13.5  ±  0.9  6.6  8.9  ±  1.9  21.5  <0.001
Hematocrit  (%)a 39.4  ±  2.7  6.7  26.7  ±  5.6  20.9  <0.001
MCV (ﬂ)a 82.3  ±  3.9  4.8  86.3  ±  11.8  13.7  <0.05
MCH (pg)  28.2  ±  1.6  5.5  28.9  ±  4.64  16.1  >0.05
MCHC (g/dl)a 34.3  ±  1.2  3.6  33.5  ±  2.1  6.2  <0.01
WBC (103/mm3)a 6.6  ±  1.4 21.2 13.8  ±  6.1 44.3  <0.001
PLA (103/mm3)a 292.4  ±  58.3 19.9 458.5  ±  199.0 43.4 <0.001
RBC, red blood cells; MCV, medium corpuscular volume; MCH, medium corpuscular hemoglobin; MCHC, medium corpuscular hemoglobin
concentration; WBC, white blood cells; PLA, platelets; CV, Pearson’s coefﬁcient of variation (%). Data are presented as mean ± standard
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a Statistically signiﬁcance difference (Student’s t-test).
extract  required  to  inhibit  pyrogallol  auto-oxidation  by  50%
was  used  to  determine  the  level  of  enzyme  activity.
Catalase  activity
The  enzyme  activity  was  determined  by  a  method  adapted
from  Beutler12 that  measures  the  rate  of  decomposition  of
hydrogen  peroxide  by  catalase  spectrophotometrically  at
240  nm.  Aliquots  of  50  L  of  40%  suspension  of  red  blood
cell  were  added  to  450  L  of  a  hemolyzing  solution  of  -
mercaptoethanol  (0.7  mmol/L)  and  EDTA  (0.27  mol/L).  This
solution  was  diluted  1:100  in  PBS  and  10  L  of  the  ﬁnal  solu-
tion  was  added  to  990  L  of  hydrogen  peroxide  solution.
The  decrease  in  absorbance  of  the  system  was  measured
for  10  min.
Intracellular  reactive  oxygen  species
Reactive  oxygen  species  were  determined  according  to  a
method  based  on  López-Revuelta  et  al.15 adapted  to  small
volumes  of  blood  samples  in  a  microplate.  Erythrocytes
(995  L  of  10%,  v/v  suspension  in  PBS)  were  incubated
with  5  L  of  dichlorodihydroﬂuorescein-diacetate  (DCFDA,
10  mol/L)  at  37 ◦C  for  30  min.  This  suspension  was  diluted
in  9.0  mL  of  PBS  and  37.5  L of  this  was  then  added  to
112.5  L  of  PBS  in  96-well  plates.  Determination  of  reac-
tive  oxygen  species  was  performed  using  a  GloMax®-Multi
Microplate  Multimode  Reader  ﬂuorimeter  (Promega  Corpo-
ration,  USA).  Under  these  conditions,  DCFDA  was  hydrolyzed
to  2′,7′-dichlorodihydroﬂuorescein  (DCFH2),  which  then
became  available  for  oxidation  by  reactive  oxygen  species  to
produce  ﬂuorescent  2,7-dichloroﬂuorescein  (DCF).  Fluores-
cence  was  determined  at  530  nm  after  excitation  at  495  nm.
Reactive  oxygen  species  formation  was  expressed  as  ﬂuores-
cence  units  (UF)/gHb.
Statistical  analysesStatistical  analysis  was  performed  using  Statistica  8.0  soft-
ware  (StatSoft,  USA).  No  outliers  were  identiﬁed.  The
Kolmogorov--Smirnov  test  was  used  to  assess  the  normal-
ity  and  all  parameters  were  distributed  normally.  Data
h
p
iere  expressed  as  mean  ±  standard  deviation  and  compared
etween  groups  using  Student’s  t-test;  a  p-value  <0.05  was
onsidered  signiﬁcant.
esults
ata  from  blood  counts  of  healthy  children  and  patients  with
ickle  cell  disease  are  illustrated  in  Table  1.  Statistically
igniﬁcant  differences  were  observed  for  all  parameters,
xcept  for  medium  corpuscular  hemoglobin  (MCH;  p  <  0.05).
Data  from  oxidative  stress  parameters  are  illustrated  in
able  2, comparing  patients  with  sickle  cell  disease  with
ealthy  children.  Statistically  signiﬁcant  differences  were
bserved  for  methemoglobin,  TBARS,  percentage  of  hemol-
sis,  G6-PD  activity,  and  reactive  oxygen  species  (p  <  0.05).
iscussion
ormal  erythrocytes  suffer  oxidative  stress  due  to  the  pro-
uction  of  reactive  oxygen  species  that  results  from  oxygen
etabolism.  However,  this  is  efﬁciently  repaired  by  the
ighly  powerful  antioxidant  systems  of  the  cell  without  any
roblematic  effect.  Oxidative  stress  occurs  as  a  result  of  an
mbalance  between  reactive  oxygen  species  production  and
ntioxidant  defenses.16
In  sickle  cell  disease,  oxidative  stress  may  result  from
igh  levels  of  meta  hemoglobin  S,  which  is  less  sta-
le  than  meta  hemoglobin  A,  leading  to  intravascular
emolysis,17 ischemia-reperfusion  injury,  chronic  inﬂamma-
ion,  and  higher  auto-oxidation  of  sickle  hemoglobin.18,19
any  potential  antioxidants  are  of  interest  in  relation  to
ickle  cell  disease,20 and  several  studies  have  demonstrated
igniﬁcant  increases  in  stress  markers  and  differing  behav-
or  in  antioxidant  defense  systems  in  patients  with  sickle  cell
isease  when  compared  to  those  in  healthy  subjects.21
The  present  results  for  blood  counts  conﬁrm  several  fea-
ures  of  sickle  cell  disease  that  are  already  known,  such
s  the  hemolytic  anemia,21 evidenced  by  low  levels  of
emoglobin7 and  increased  levels  of  white  blood  cells  and
latelets.6
As  previously  demonstrated,8 methemoglobin  levels  are
ncreased  in  individuals  with  sickle  cell  disease.  There  is
398  Hermann  PB  et  al.
Table  2  Oxidative  stress  parameters  in  normal  children  (control  group)  and  patients  with  sickle  cell  disease.
Control  group  Patients  p
n =  100 n  =  45
METHb  (%)a 2.2  ±  0.4  4.5  ±  1.1  <0.001
GSH (mol/gHb)  6.4  ±  1.4  6.6  ±  2.3  >0.05
TBARS (nmol/gHb)a 24.6  ±  5.8  41.5  ±  20.1  <0.001
HEMO 0a,b 1.1  ±  0.4  4.7  ±  1.7  <0.001
HEMO 50a,b 25.0  ±  7.9  49.2  ±  19.4  <0.001
HEMO 100a,b 55.5  ±  10.2  80.7  ±  13.6  <0.001
HEMO 150a,b 80.1  ±  7.5 92.6  ±  5.1 <0.001
G6-PD (U/gHb)a 6.2  ±  1.1 13.2  ±  3.3 <0.001
SOD (U/gHb) 1846.1  ±  457.2 1832.4  ±  647.1 >0.05
CAT (U/gHb)  2.6  105 ±  6.6  104 2.9·105 ±  8.5·104 >0.05
ROS (UF/gHb)a 1468.0  ±  296.2  2427.5  ±  1110.3  <0.001
METHb, methemoglobin; GSH, reduced glutathione; TBARS, thiobarbituric acid reactive substances; HEMO, hemolysis; G6-PD, glucose 6-
phosphate dehydrogenase; SOD, superoxide dismutase; CAT, catalase; ROS, reactive oxygen species. Data presented as mean ± standard
deviation.
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b Percentages of hemolysis with addition of 0--150 mmol/L of AA
n  electron  transfer  in  the  bonding  interaction  between
he  heme  and  the  oxygen  (O2)  in  oxygenated  hemoglobin.
hen  hemoglobin  deoxygenates,  the  heme  iron  normally
emains  in  the  ferrous  state.20 In  this  exchange,  alterations
herein  hemoglobin  autoxidizes  result  in  methemoglobin,
ith  the  heme  iron  in  ferric  state.8 Alterations  in  erythro-
yte  function  or  structure  can  lead  to  an  enhanced  ﬂow  of
ethemoglobin  that  can  lead  to  oxidative  stress.15
The  increased  intra-  and  extra-erythrocytic  oxidative
tress  induces  lipid  peroxidation  and  membrane  instability.14
BARS  is  one  of  the  existing  biomarkers,  and  this  evaluation
s  an  indirect  quantiﬁcation  of  lipid  peroxidation  processes,
hich  makes  it  a  good  indicator  of  pro-oxidant  stimuli.
n  accordance  with  results  reported  previously,19,20,22 the
resent  study  observed  signiﬁcantly  higher  levels  of  TBARS
n  patients  with  sickle  cell  disease  than  in  the  controls.
Rigid  and  deformed  sickle  erythrocytes  have  a  shortened
ifespan  and  undergo  both  intravascular  and  extravascular
emolysis.23 Higher  percentages  of  hemolysis  in  erythrocyte
rom  children  with  sickle  cell  disease  than  in  the  control
roup  were  observed,  both  in  basal  suspensions  of  erythro-
ytes  and  in  suspensions  incubated  with  an  oxidizing  agent.
G6-PD  is  an  important  enzyme  related  to  the  antioxidant
efense  in  erythrocytes.20 Higher  activity  of  this  enzyme
n  patients  with  sickle  cell  disease  was  found  than  in  the
ontrol  group.  It  was  previously  reported  that  erythrocytes
rom  patients  with  sickle  cell  disease  have  an  increased
ercentage  of  reticulocytes,  while  the  activity  of  G6-PD  in
eticulocytes  is  normal,  but  declines  exponentially  as  the
ed  cells  age.24
Sickle  cells  spontaneously  generate  approximately  two
imes  more  reactive  oxygen  species  than  normal  red  blood
ells.25 In  accordance  with  the  ﬁndings  of  George  et  al.,26
levated  levels  of  reactive  oxygen  species  in  sickle  erythro-
ytes  were  also  demonstrated.
Reduced  glutathione  (GSH)  is  present  at  high  concentra-
ions  in  erythrocytes  and  acts  by  itself  or  via  glutathione
eroxidase  as  a  major  reducing  source  to  maintain  cell
ntegrity.17 The  measurements  of  GSH  and  its  oxidized  form
o
t
alutions.
lutathione  disulﬁde  (GSSG)  have  been  considered  useful
ndicators  of  in  vivo  oxidative  stress.27 The  majority  of  stud-
es  of  adults  with  sickle  cell  disease  reported  some  deﬁcits  of
ndogenous  synthesis  of  GSH,  probably  due  to  its  consump-
ion  by  increased  oxidant  production.26,28 Although  Rusanova
t  al.22 showed  high  levels  of  GSH  in  pediatric  patients  with
ickle  cell  disease,  the  present  study  found  no  difference  in
SH  levels  between  children  with  sickle  cell  disease  and  the
ontrol  group.
Superoxide  dismutase  can  convert  superoxide  to  hydro-
en  peroxide,  and  catalase  can  remove  excess  hydrogen
eroxide.16 According  to  Silva  et  al.,20 the  increased  pro-
xidant  generation  in  sickle  cell  disease  results  in  an
ntioxidant  deﬁciency.  However,  there  are  some  discrepan-
ies  between  studies  on  superoxide  dismutase  and  catalase
evels  in  this  disease,  with  some  studies  observing  increased
ctivity  and  others  observing  decreased  levels.29 An  increase
n  these  enzymes  activity  potentially  constitutes  a  defense
echanism  in  response  to  increased  oxidative  stress,19 or
ight  be  a  consequence  of  increased  reticulocyte  content
n  blood  samples  from  patients  with  sickle  cell  disease.
owever,  a  decrease  in  enzyme  levels  was  related  to  dis-
ase  severity  in  patients.20,22 These  seemingly  contradictory
ndings  could  be  due  to  differences  in  the  extent  of  oxida-
ive  stress,  disease  severity,  enzyme  polymorphism,  and
he  enzyme  co-factor.29 The  present  results  showed  no
ifference  between  the  activities  of  these  enzymes  in  chil-
ren  with  sickle  cell  disease  and  those  in  healthy  children,
ccording  with  Cho  et  al.30 with  regard  to  catalase.  These
esults  may  be  due  to  large  individual  variability  found
mong  patients.
In light  of  evidence  suggesting  that  an  excess  of  oxidative
tress  has  implications  in  sickle  cell  disease  pathophysio-
ogy,  the  assessment  of  oxidative  stress  parameters  in  these
atients  may  provide  useful  information  regarding  the  use
f  current  medications  and  may  lead  to  the  development
f  new  therapeutic  strategies.10,19,20 Monitoring  the  oxida-
ive  stress  involves  the  observation  of  different  parameters
ssociated  with  pro-oxidant  and  antioxidant  biomarkers.27
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However,  the  use  of  an  isolated  biomarker  and  the  mea-
surement  of  individual  antioxidants  are  not  likely  to  be
useful  indexes  of  oxidative  status.  The  oxidant--antioxidant
balance  involves  biochemical  reactions  that  require  the
evaluation  of  many  endpoints.26
The  present  study  evaluated  eight  oxidative  stress  mark-
ers,  including  pro-oxidant  and  antioxidant  parameters.  The
results  indicate  the  presence  of  a  hyperoxidative  status  in
children  with  sickle  cell  disease,  which  can  be  observed  by
their  high  levels  of  methemoglobin,  TBARS,  hemolysis,  reac-
tive  oxygen  species,  and  G6-PD  activity.  Simple  techniques
were  used  to  determine  these  parameters  using  small  vol-
umes  of  blood.  These  parameters  that  appeared  altered  in
children  with  sickle  cell  disease  can  be  useful  in  the  evalu-
ation  of  disease  progression  and  treatment.
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